Pain Management Market Size, Share & Trends Analysis Report By Drug Class (NSAIDs, Anticonvulsants, Antidepressants, Anti-migraine agents, Non-narcotic analgesics, Opioids), By Route of Administration (Oral, Parenteral) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: March 05, 2026 | Author: Debashree B | Format: | Report Code: SR4390DR | Pages: 160

Market Segmentation

  1. Pain Management Market, By Drug Class 2022-2034 (USD MILLION/ Units)
    1. NSAIDs
    2. Anticonvulsants
    3. Antidepressants
    4. Anti-migraine agents
    5. Non-narcotic analgesics
    6. Opioids
  2. Pain Management Market, By Route of Administration 2022-2034 (USD MILLION/ Units)
    1. Oral
    2. Parenteral
  3. Regional Pain Management Market
    1. North America
      1. North America Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. NSAIDs
        2. Anticonvulsants
        3. Antidepressants
        4. Anti-migraine agents
        5. Non-narcotic analgesics
        6. Opioids
      2. North America Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
      3. U.S. Pain Management Market
        1. U.S. Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. U.S. Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      4. Canada Pain Management Market
        1. Canada Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Canada Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
    2. Europe
      1. Europe Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. NSAIDs
        2. Anticonvulsants
        3. Antidepressants
        4. Anti-migraine agents
        5. Non-narcotic analgesics
        6. Opioids
      2. Europe Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
      3. U.K. Pain Management Market
        1. U.K. Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. U.K. Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      4. Germany Pain Management Market
        1. Germany Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Germany Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      5. France Pain Management Market
        1. France Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. France Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      6. Spain Pain Management Market
        1. Spain Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Spain Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      7. Italy Pain Management Market
        1. Italy Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Italy Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      8. Russia Pain Management Market
        1. Russia Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Russia Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      9. Nordic Pain Management Market
        1. Nordic Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Nordic Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      10. Benelux Pain Management Market
        1. Benelux Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Benelux Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      11. Rest of Europe Pain Management Market
        1. Rest of Europe Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Rest of Europe Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
    3. APAC
      1. APAC Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. NSAIDs
        2. Anticonvulsants
        3. Antidepressants
        4. Anti-migraine agents
        5. Non-narcotic analgesics
        6. Opioids
      2. APAC Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
      3. China Pain Management Market
        1. China Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. China Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      4. Korea Pain Management Market
        1. Korea Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Korea Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      5. Japan Pain Management Market
        1. Japan Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Japan Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      6. India Pain Management Market
        1. India Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. India Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      7. Australia Pain Management Market
        1. Australia Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Australia Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      8. Taiwan Pain Management Market
        1. Taiwan Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Taiwan Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      9. South East Asia Pain Management Market
        1. South East Asia Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. South East Asia Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      10. Rest of Asia-Pacific Pain Management Market
        1. Rest of Asia-Pacific Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Rest of Asia-Pacific Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
    4. Middle East and Africa
      1. Middle East and Africa Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. NSAIDs
        2. Anticonvulsants
        3. Antidepressants
        4. Anti-migraine agents
        5. Non-narcotic analgesics
        6. Opioids
      2. Middle East and Africa Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
      3. UAE Pain Management Market
        1. UAE Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. UAE Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      4. Turkey Pain Management Market
        1. Turkey Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Turkey Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      5. Saudi Arabia Pain Management Market
        1. Saudi Arabia Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Saudi Arabia Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      6. South Africa Pain Management Market
        1. South Africa Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. South Africa Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      7. Egypt Pain Management Market
        1. Egypt Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Egypt Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      8. Nigeria Pain Management Market
        1. Nigeria Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Nigeria Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      9. Rest of MEA Pain Management Market
        1. Rest of MEA Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Rest of MEA Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
    5. LATAM
      1. LATAM Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
        1. NSAIDs
        2. Anticonvulsants
        3. Antidepressants
        4. Anti-migraine agents
        5. Non-narcotic analgesics
        6. Opioids
      2. LATAM Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
        1. Oral
        2. Parenteral
      3. Brazil Pain Management Market
        1. Brazil Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Brazil Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      4. Mexico Pain Management Market
        1. Mexico Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Mexico Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      5. Argentina Pain Management Market
        1. Argentina Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Argentina Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      6. Chile Pain Management Market
        1. Chile Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Chile Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      7. Colombia Pain Management Market
        1. Colombia Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Colombia Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
      8. Rest of LATAM Pain Management Market
        1. Rest of LATAM Pain Management Market By Drug Class 2022-2034 (USD MILLION/ Units)
          1. NSAIDs
          2. Anticonvulsants
          3. Antidepressants
          4. Anti-migraine agents
          5. Non-narcotic analgesics
          6. Opioids
        2. Rest of LATAM Pain Management Market By Route of Administration 2022-2034 (USD MILLION/ Units)
          1. Oral
          2. Parenteral
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on: